Lazard Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 19 shares of ARWR stock, worth $352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 2,328 99.18%

Holding current value

$352

Previous $60,000 100.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $44,702 - $68,207	-2,309 Reduced 99.18%	19 $0
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $28,452 - $36,740	-1,301 Reduced 35.85%	2,328 $60,000
Q1 2024 May 14, 2024	SELL	$27.21 - $39.48 $11,863 - $17,213	-436 Reduced 10.73%	3,629 $102,000
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $996 - $1,458	47 Added 1.17%	4,065 $124,000
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $41,631 - $57,331	1,589 Added 65.42%	4,018 $107,000
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $32,305 - $53,131	-1,284 Reduced 34.58%	2,429 $86,000
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $13,402 - $21,796	566 Added 17.99%	3,713 $94,000
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $18,592 - $26,931	-664 Reduced 17.42%	3,147 $127,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $207 - $338	7 Added 0.18%	3,811 $125,000
Q2 2022 Aug 09, 2022	BUY	$27.79 - $50.61 $52,161 - $94,994	1,877 Added 97.41%	3,804 $133,000
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $20,760 - $36,664	524 Added 37.35%	1,927 $87,000
Q4 2021 Feb 09, 2022	SELL	$58.09 - $82.51 $1.48 Million - $2.1 Million	-25,444 Reduced 94.77%	1,403 $92,000
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $1.42 Million - $2.07 Million	24,317 Added 961.15%	26,847 $1.68 Million
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $154,939 - $225,167	2,493 Added 6737.84%	2,530 $209,000
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $1,621 - $3,158	37 New	37 $2,000
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $15,419 - $47,340	-750 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $21,105 - $54,757	750 New	750 $47,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.97B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History